Skip to main content
    M

    Mediwound Ltd (MDWD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.68
    +0.13 (+0.96%)

    Market Cap: $185.63M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Mediwound Ltd (MDWD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Mediwound (MDWD) has a market cap of $185.63M and an enterprise value of $166.09M. It kept -234.98% of revenue as net income over the last 12 months. Its share count is up 18.15% from a year earlier.

    Total Valuation

    Enterprise value is 10.53% below the market cap, as cash exceeds debt.

    Market Cap$185.63M
    Enterprise Value$166.09M
    Latest price (Nov 17, 2026)$13.68

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.08% in the quarter ended Sep 30, 2026 and grew 11.31% a year over 2 years.

    Shares Outstanding13.02M
    Shares Change (YoY)+18.15%
    Shares Change (QoQ)+1.08%
    Share Count Growth (2Y CAGR)+11.31%

    Valuation Ratios

    Sales and book value multiples are 17.8x and 5.6x. Its year-end P/S ranged from 2.6x to 64.2x from 2016 to 2025.

    P/S Ratio17.8x
    Forward P/S9.0x
    P/B Ratio5.6x

    Valuation history and multiples

    Price Statistics

    The stock is down 25.04% over 52 weeks and trades 3.56% above its 50-day average.

    Beta (1Y)0.77
    52-Week Change-25.04%
    1-Month Change+7.72%
    3-Month Change+0.66%
    6-Month Change-18.01%
    5-Year Change-46.01%
    10-Year Change-70.30%
    Total Return (1Y)-25.04%
    Total Return (3Y CAGR)+17.98%
    Total Return (5Y CAGR)-7.34%
    Return vs SPY (1Y)-36.72%
    Max Drawdown (1Y)-38.82%
    Max Drawdown (3Y)-46.72%
    Sharpe Ratio (1Y)-0.68
    Correlation with SPY (1Y)0.25
    50-Day Average$13.21
    200-Day Average$15.00
    52-Week Range$11.80 to $19.70
    RSI (14 Days)53.8
    Average Volume (20 Days)164.72K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.23x current liabilities, and total debt is 0.26x shareholder equity.

    Current Ratio2.23x
    Quick Ratio1.99x
    Debt / Equity0.26x

    Returns and Efficiency

    Return on invested capital is -66.94% over the last 12 months, against a 5-year average of 100.62%.

    Return on Equity (ROE)-73.97%
    Return on Assets (ROA)-35.90%
    Return on Invested Capital (ROIC)-66.94%
    ROA (5Y Average)-37.35%
    ROIC (5Y Average)100.62%
    Asset Turnover0.13x
    Inventory Turnover2.03x
    Receivables Turnover2.60x
    Cash Conversion Cycle-27 days

    Scores

    MDWD has an Altman Z-Score of 2.33, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.33
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $10.01M over the last 12 months is down 52.19% from the 12 months before.

    Revenue$10.01M
    Revenue Growth (YoY)-52.19%
    Gross Profit$1.95M
    Operating Income-$33.80M
    Pretax Income-$23.34M
    Net Income-$23.51M
    Reported EPS (TTM)-$2.21

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 48.53% of the $65.50M in total assets.

    Cash and Equivalents$27.85M
    Total Debt$8.30M
    Net Cash$19.55M
    Net Cash Per Share$1.50
    Working Capital$19.77M
    Shareholder Equity$31.79M
    Book Value Per Share$2.44
    Total Assets$65.50M
    Total Liabilities$33.70M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $6.14M of capital spending, operating cash flow left -$32.56M of free cash flow.

    Operating Cash Flow-$26.41M
    Capital Expenditures$6.14M
    Free Cash Flow-$32.56M
    FCF Per Share-$2.26
    Depreciation and Amortization$1.86M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -337.76%, against a 5-year average of -80.80%.

    Gross Margin19.54%
    Operating Margin-337.76%
    Pretax Margin-233.25%
    Net Margin-234.98%
    FCF Margin-325.33%
    Gross Margin (5Y Average)27.59%
    Operating Margin (5Y Average)-80.80%
    Net Margin (5Y Average)-91.44%

    Growth

    Revenue fell 13.82% a year over 3 years.

    Revenue Growth (3Y CAGR)-13.82%
    Revenue Growth (5Y CAGR)-4.87%
    Book Value Per Share Growth (2Y CAGR)-0.36%
    Tangible Book Per Share Growth (2Y CAGR)-0.14%

    Revenue and profit by year

    Dividends and Yields

    MDWD does not pay a dividend. Its free cash flow yield is -18.27%.

    FCF Yield-18.27%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-7 reverse split on Dec 20, 2022.

    Last Split DateDec 20, 2022
    Split TypeReverse split
    Split Ratio1:7

    Peer Position

    Against 7 similar companies, MDWD has the 4th highest P/S.

    P/S Ratio17.8x vs 2.8x median
    Revenue Growth (Trailing 4 Quarters, YoY)-52.19% vs +2.54% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 31.11% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+31.11%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MDWD

    What is MDWD's market cap?

    Mediwound has a market cap of $185.63M. Its enterprise value, which adds debt and subtracts cash, is $166.09M.

    How many shares of MDWD are outstanding?

    Mediwound has 13.02M shares outstanding. The count is up 18.15% from a year earlier.

    Does MDWD pay a dividend?

    No. Mediwound does not pay a dividend.

    How much debt does MDWD have?

    Mediwound has $8.30M of total debt and $27.85M of cash and equivalents, a net cash position of $19.55M.